Peter Salzmann
Equibles does not estimate personal net worth.
About Peter Salzmann
Earlier roles on record: CEO at Immunovant, Inc. (IMVT) until April 20, 2025 and Board Member at Immunovant, Inc. (IMVT) until April 18, 2025. The proxy statement of Immunovant, Inc. reports total compensation of $15,334,600 for Peter Salzmann in fiscal 2026, including a base salary of $39,614. Disclosed compensation is on record for 7 fiscal years.
Affiliation history
-
Start not stated–2025-04-18
-
Start not stated–2025-04-20
Company network
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2026 | Immunovant, Inc. (IMVT) | Former Chief Executive Officer | $39,614 | $15,334,600 |
| 2025 | Immunovant, Inc. (IMVT) | Former Chief Executive Officer | $724,500 | $10,732,127 |
| 2024 | Immunovant, Inc. (IMVT) | Former Chief Executive Officer | $700,000 | $8,552,430 |
| 2023 | Immunovant, Inc. (IMVT) | Former Chief Executive Officer | $625,000 | $5,819,818 |
| 2022 | Immunovant, Inc. (IMVT) | M.D., M.B.A. Chief Executive Officer | $600,000 | $5,868,341 |
| 2021 | Immunovant, Inc. (IMVT) | M.D., M.B.A. Chief Executive Officer | $567,000 | $15,375,304 |
| 2019 | Immunovant, Inc. (IMVT) | M.D., M.B.A. Chief Executive Officer | $361,010 | $8,806,834 |
Recent activity
No call appearances or filed executive changes recorded yet.